BBHC
BLUE

Brown Brothers Harriman & Co’s bluebird bio BLUE Stock Holding History

Brown Brothers Harriman & Co’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Hold
0
– – – 1125
2019
Q3 		– Hold
0
– – – 1195
2019
Q2 		– Hold
0
– – – 1110
2018
Q1 		– Sell
-1
Closed -$2K – 837
2017
Q4 		$2K Buy
+1
New +$2.03K ﹤0.01% 1022

Other funds holding BLUE

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Brown Brothers Harriman & Co's BLUE Position: Q4 2019 in Review

Brown Brothers Harriman & Co held its bluebird bio (BLUE) position steady in Q4 2019 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #1125.

Brown Brothers Harriman & Co first reported a position in BLUE in Q4 2017 and has held it in 1 quarter since. The position peaked at $2K in Q4 2017. 274 funds tracked by Wall St. Rank hold BLUE as of Q4 2019.

  • Brown Brothers Harriman & Co held 0 shares of bluebird bio worth $0 as of Q4 2019.
  • Brown Brothers Harriman & Co left its bluebird bio share count unchanged in Q4 2019.
  • bluebird bio made up ﹤0.01% of Brown Brothers Harriman & Co's portfolio in Q4 2019, its #1125 holding.
  • Brown Brothers Harriman & Co first reported a position in bluebird bio in Q4 2017 and has held it in 1 quarter since.
  • Brown Brothers Harriman & Co's bluebird bio position peaked at $2K in Q4 2017.
  • 274 funds tracked by Wall St. Rank held bluebird bio as of Q4 2019.

Based on Brown Brothers Harriman & Co's 13F filing for Q4 2019, filed 14 Feb 2020.